Pages that link to "Q54453648"

The following pages link to Endogenous catecholamine levels in chronic heart failure. Relation to the severity of hemodynamic abnormalities. (Q54453648):

Displaying 45 items.

• Stress-echocardiography in idiopathic dilated cardiomyopathy: instructions for use (Q24795840) (← links)
• Role of echocardiography in diagnosis and risk stratification in heart failure with left ventricular systolic dysfunction. (Q30500004) (← links)
• Intravenous fenoldopam infusion in severe heart failure (Q33492163) (← links)
• Sudden death in dilated cardiomyopathy (Q33591383) (← links)
• Neuroendocrine activity in untreated heart failure (Q33611263) (← links)
• The acute effects of a single dopamine infusion in elderly patients with congestive cardiac failure. (Q34346128) (← links)
• Heart failure and neuroendocrine activation: diagnostic, prognostic and therapeutic perspectives (Q34448373) (← links)
• Carvedilol in the failing heart. (Q34478931) (← links)
• Calibration of baroreflex equilibrium diagram based on exogenous pressor agents in chronic heart failure rats (Q35057391) (← links)
• Drug therapy in chronic heart failure (Q35518236) (← links)
• Head-to-head comparison of indices of left ventricular contractile reserve assessed by high-dose dobutamine stress echocardiography in idiopathic dilated cardiomyopathy: five-year follow up. (Q35772418) (← links)
• Endocrine aspects of acute and prolonged critical illness (Q36576950) (← links)
• Adaptation of renal function in heart failure. (Q36627825) (← links)
• Acute arterial baroreflex-mediated changes in plasma catecholamine concentrations in a chronic rat model of myocardial infarction (Q37176724) (← links)
• Vasodilator therapy without converting-enzyme inhibition in congestive heart failure--usefulness and limitations (Q38215916) (← links)
• Renal and circulatory mechanisms in congestive heart failure (Q39482471) (← links)
• The rational selection of inotropic drugs in cardiac surgery (Q39491508) (← links)
• Vasodilator therapy in chronic congestive heart failure (Q39649933) (← links)
• Aggravated renal dysfunction during intensive therapy for advanced chronic heart failure (Q40803607) (← links)
• Sympathetic dysfunction in heart failure (Q40905075) (← links)
• Cardiac autonomic modulation induced by doxorubicin in a rodent model of colorectal cancer and the influence of fullerenol pretreatment (Q41072198) (← links)
• Effects of ACE inhibition with cilazapril on splanchnic and systemic haemodynamics in man (Q41971515) (← links)
• Resveratrol enhances the inotropic effect but inhibits the proarrhythmic effect of sympathomimetic agents in rat myocardium (Q42293112) (← links)
• Clinical characteristics of patients with increased urinary excretion of adrenaline in mild to moderate heart failure. (Q43566109) (← links)
• Oral L-arginine prevents murine coxsackievirus B3 myocarditis (Q44207422) (← links)
• Effects of desipramine on norepinephrine clearance in congestive heart failure (Q44398685) (← links)
• Basal and exercise-induced neuroendocrine activation in patients with heart failure and in normal subjects (Q44794225) (← links)
• Effects of dopexamine, dobutamine or dopamine on prolactin and thyreotropin serum concentrations in high-risk surgical patients (Q44892806) (← links)
• Neuronal nitric oxide synthase gene transfer decreases [Ca2 ]i in cardiac sympathetic neurons (Q44937907) (← links)
• BNP and ANP as diagnostic and predictive markers in heart failure with left ventricular systolic dysfunction (Q45139069) (← links)
• Effects of dopamine on cellular and humoral immune responses in septic patients (Q46583441) (← links)
• A common humoral background of intraocular and arterial blood pressure dysregulation. (Q50010662) (← links)
• Neuroendocrine activation in relation to left ventricular function in chronic severe congestive heart failure: A subgroup analysis from the cooperative north scandinavian enalapril survival study (CONSENSUS) (Q57651227) (← links)
• Evidence of a Selective Increase in Cardiac Sympathetic Activity in Patients with Sustained Ventricular Arrhythmias (Q67927748) (← links)
• Myocardial beta-adrenoceptor density and the distribution of beta 1- and beta 2-adrenoceptor subpopulations in children with congenital heart disease (Q68238168) (← links)
• Influence of cardiovascular diseases upon the results of the cardiovascular reflex tests in diabetic and nondiabetic subjects (Q68778873) (← links)
• Selection of patients for cardiac transplantation (Q68931353) (← links)
• Role of spectral measures of heart rate variability as markers of disease progression in patients with chronic congestive heart failure not treated with angiotensin-converting enzyme inhibitors (Q70880316) (← links)
• Dehydroepiandrosterone sulphate in critical illness: effect of dopamine (Q71808465) (← links)
• Iodine-123 metaiodobenzylguanidine images reflect intense myocardial adrenergic nervous activity in congestive heart failure independent of underlying cause (Q71827421) (← links)
• Resting heart rate and cardiac function in dilated cardiomyopathy (Q73357073) (← links)
• Influence of hemodynamic changes on neuroendocrine response in acute heart failure (Q73597768) (← links)
• Usefulness of Low Doses of Atropine to Quantify the Vagal Stimulus-Response Relation in Patients With Congestive Heart Failure (Q73943127) (← links)
• The sympathetic nervous system in chronic heart failure (Q77141939) (← links)
• Catestatin in Acutely Decompensated Heart Failure Patients: Insights from the CATSTAT-HF Study (Q92318639) (← links)